⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GTBP News
GT Biopharma Inc. Common Stock
"Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies
globenewswire.com
GTBP
VIR
ONCY
SNSE
A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology
globenewswire.com
GTBP
SMMT
IDYA
RADX
Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth Phase
prnewswire.com
GTBP
ARTV
FATE
IBRX
CHRS
GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors
globenewswire.com
GTBP
Replays from RedChip's Biotech Investor Conference Now Available
accessnewswire.com
KYNB
ANIX
GTBP
RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation
accessnewswire.com
KYNB
ANIX
GTBP
Form 8-K
sec.gov
GTBP
GT Biopharma to Participate in the 38th Annual Roth Conference
globenewswire.com
GTBP
Form 8-K
sec.gov
GTBP
GT Biopharma Reports Full Year 2025 Financial Results
globenewswire.com
GTBP